BriaCell 2024 AACR Preclinical Poster Confirms Strong Anti-Cancer Activity of Bria-OTS+(TM) and Bria-PROS+(TM) Clinical Candidates for Breast and Prostate Cancer
Stock Information for BriaCell Therapeutics Corp.
Loading
Please wait while we load your information from QuoteMedia.